Orbimed Advisors as of March 31, 2020
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 140 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ascendis Pharma A S (ASND) | 6.2 | $370M | 3.3M | 112.61 | |
Tricida | 3.6 | $212M | 9.6M | 22.00 | |
Alector (ALEC) | 3.4 | $201M | 8.3M | 24.13 | |
Springworks Therapeutics (SWTX) | 3.4 | $200M | 7.4M | 27.00 | |
Merck & Co (MRK) | 3.3 | $199M | 2.6M | 76.94 | |
Alexion Pharmaceuticals | 3.1 | $186M | 2.1M | 89.79 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.9 | $176M | 737k | 237.95 | |
Prevail Therapeutics Ord | 2.8 | $169M | 14M | 12.19 | |
Iovance Biotherapeutics (IOVA) | 2.8 | $166M | 5.5M | 29.93 | |
Boston Scientific Corporation (BSX) | 2.7 | $158M | 4.8M | 32.63 | |
Biogen Idec (BIIB) | 2.6 | $152M | 480k | 316.38 | |
Arcutis Biotherapeutics (ARQT) | 2.3 | $139M | 4.7M | 29.80 | |
Bristol Myers Squibb (BMY) | 2.3 | $138M | 2.5M | 55.74 | |
Turning Point Therapeutics I | 2.1 | $123M | 2.7M | 44.66 | |
Pfizer (PFE) | 1.9 | $115M | 3.5M | 32.64 | |
Gilead Sciences (GILD) | 1.8 | $110M | 1.5M | 74.76 | |
Passage Bio (PASG) | 1.8 | $110M | 7.0M | 15.75 | |
Mirati Therapeutics | 1.8 | $109M | 1.4M | 76.87 | |
89bio (ETNB) | 1.7 | $101M | 4.0M | 25.25 | |
Nextcure (NXTC) | 1.7 | $101M | 2.7M | 37.07 | |
Neurocrine Biosciences (NBIX) | 1.7 | $100M | 1.2M | 86.55 | |
Natera (NTRA) | 1.7 | $100M | 3.3M | 29.86 | |
Dex (DXCM) | 1.5 | $91M | 338k | 269.27 | |
eHealth (EHTH) | 1.5 | $90M | 639k | 140.82 | |
Sarepta Therapeutics (SRPT) | 1.5 | $88M | 902k | 97.82 | |
Humana (HUM) | 1.5 | $88M | 280k | 314.02 | |
Intuitive Surgical (ISRG) | 1.4 | $84M | 169k | 495.21 | |
Centene Corporation (CNC) | 1.3 | $79M | 1.3M | 59.41 | |
Cigna Corp (CI) | 1.3 | $78M | 440k | 177.18 | |
Bellus Health | 1.2 | $69M | 7.0M | 9.87 | |
Horizon Therapeutics | 1.2 | $69M | 2.3M | 29.62 | |
Agios Pharmaceuticals (AGIO) | 1.1 | $68M | 1.9M | 35.48 | |
Hca Holdings (HCA) | 1.1 | $64M | 710k | 89.85 | |
Stryker Corporation (SYK) | 1.0 | $62M | 371k | 166.49 | |
Exelixis (EXEL) | 0.9 | $55M | 3.2M | 17.22 | |
Ptc Therapeutics I (PTCT) | 0.9 | $51M | 1.1M | 44.61 | |
Meiragtx Holdings (MGTX) | 0.8 | $48M | 3.6M | 13.44 | |
Glaukos (GKOS) | 0.8 | $48M | 1.5M | 30.86 | |
Deciphera Pharmaceuticals | 0.8 | $48M | 1.2M | 41.17 | |
Kala Pharmaceuticals | 0.8 | $48M | 5.4M | 8.79 | |
Uniqure Nv (QURE) | 0.8 | $47M | 984k | 47.45 | |
BioMarin Pharmaceutical (BMRN) | 0.8 | $46M | 541k | 84.50 | |
Imara | 0.7 | $44M | 2.7M | 16.03 | |
Applied Therapeutics (APLT) | 0.7 | $43M | 1.3M | 32.69 | |
Arvinas Ord (ARVN) | 0.7 | $40M | 995k | 40.30 | |
Bausch Health Companies (BHC) | 0.6 | $37M | 2.4M | 15.50 | |
Adverum Biotechnologies | 0.6 | $34M | 3.5M | 9.77 | |
Edwards Lifesciences (EW) | 0.6 | $33M | 177k | 188.62 | |
Logicbio Therapeutics | 0.5 | $32M | 6.5M | 4.94 | |
Thermo Fisher Scientific (TMO) | 0.5 | $31M | 110k | 283.60 | |
AtriCure (ATRC) | 0.5 | $31M | 928k | 33.59 | |
Prothena (PRTA) | 0.5 | $31M | 2.9M | 10.70 | |
Athenex | 0.5 | $31M | 4.0M | 7.74 | |
Crinetics Pharmaceuticals In (CRNX) | 0.5 | $30M | 2.0M | 14.70 | |
Nanostring Technologies (NSTGQ) | 0.5 | $29M | 1.2M | 24.05 | |
Harpoon Therapeutics | 0.5 | $28M | 2.4M | 11.58 | |
Acadia Healthcare (ACHC) | 0.4 | $25M | 1.4M | 18.35 | |
Scpharmaceuticals (SCPH) | 0.4 | $25M | 3.4M | 7.40 | |
Tela Bio (TELA) | 0.4 | $24M | 3.0M | 7.82 | |
Crispr Therapeutics (CRSP) | 0.4 | $23M | 551k | 42.41 | |
Acceleron Pharma | 0.4 | $23M | 258k | 89.87 | |
Benefytt Technologies Cl A Ord | 0.4 | $22M | 963k | 22.39 | |
Amgen (AMGN) | 0.4 | $21M | 105k | 202.73 | |
Inspire Med Sys (INSP) | 0.4 | $21M | 347k | 60.28 | |
Zymeworks | 0.3 | $21M | 582k | 35.47 | |
Novo Nordisk A/S (NVO) | 0.3 | $20M | 330k | 60.20 | |
Aurinia Pharmaceuticals (AUPH) | 0.3 | $19M | 1.3M | 14.51 | |
Iqvia Holdings (IQV) | 0.3 | $19M | 175k | 107.86 | |
Xenon Pharmaceuticals (XENE) | 0.3 | $19M | 1.7M | 11.34 | |
Alcon (ALC) | 0.3 | $18M | 351k | 51.07 | |
Abbvie (ABBV) | 0.3 | $17M | 229k | 76.19 | |
Sinovac Biotech (SVA) | 0.3 | $17M | 2.8M | 6.04 | |
Si-bone (SIBN) | 0.3 | $17M | 1.4M | 11.95 | |
Chardan Healthcare Acqu- Ord (PHGE) | 0.3 | $16M | 2.3M | 7.00 | |
Verrica Pharmaceuticals (VRCA) | 0.3 | $16M | 1.5M | 10.93 | |
Spdr S&p 500 Etf (SPY) | 0.3 | $16M | 50k | 315.48 | |
Sierra Oncology | 0.2 | $15M | 1.5M | 9.82 | |
Corvus Pharmaceuticals (CRVS) | 0.2 | $14M | 6.8M | 2.11 | |
Aeglea Biotherapeutics | 0.2 | $13M | 2.9M | 4.66 | |
Zai Lab (ZLAB) | 0.2 | $13M | 254k | 51.48 | |
Pfenex | 0.2 | $12M | 1.3M | 8.82 | |
X4 Pharmaceuticals (XFOR) | 0.2 | $11M | 1.1M | 10.00 | |
Alpine Immune Sciences | 0.2 | $11M | 3.7M | 2.88 | |
Neoleukin Therapeutics | 0.2 | $11M | 922k | 11.38 | |
Avrobio Ord (AVRO) | 0.2 | $10M | 663k | 15.56 | |
Health Care SPDR (XLV) | 0.2 | $10M | 113k | 88.58 | |
SPDR S&P Biotech (XBI) | 0.2 | $9.8M | 127k | 77.44 | |
Cti Biopharma | 0.1 | $8.8M | 9.5M | 0.92 | |
Regenxbio Inc equity us cm (RGNX) | 0.1 | $8.7M | 268k | 32.38 | |
Regeneron Pharmaceuticals (REGN) | 0.1 | $8.4M | 17k | 488.31 | |
Mersana Therapeutics (MRSN) | 0.1 | $7.9M | 1.3M | 5.83 | |
Cara Therapeutics (CARA) | 0.1 | $7.8M | 593k | 13.21 | |
Adaptimmune Therapeutics (ADAP) | 0.1 | $6.9M | 2.5M | 2.72 | |
Revolution Medicines (RVMD) | 0.1 | $6.6M | 300k | 21.91 | |
Heron Therapeutics (HRTX) | 0.1 | $6.3M | 537k | 11.74 | |
Obseva Sa | 0.1 | $6.3M | 2.6M | 2.41 | |
Selecta Biosciences | 0.1 | $6.3M | 2.6M | 2.41 | |
Xtant Med Hldgs (XTNT) | 0.1 | $6.2M | 9.2M | 0.67 | |
Essa Pharma (EPIX) | 0.1 | $5.9M | 1.5M | 4.00 | |
10x Genomics Inc Cl A (TXG) | 0.1 | $5.8M | 93k | 62.32 | |
Arena Pharmaceuticals | 0.1 | $5.6M | 133k | 42.00 | |
Anaptysbio Inc Common (ANAB) | 0.1 | $5.3M | 376k | 14.13 | |
Verona Pharma Plc ads (VRNA) | 0.1 | $5.2M | 1.3M | 4.12 | |
Restorbio | 0.1 | $5.0M | 4.8M | 1.03 | |
Theravance Biopharma (TBPH) | 0.1 | $4.9M | 212k | 23.11 | |
Health Catalyst (HCAT) | 0.1 | $4.7M | 180k | 26.15 | |
Menlo Therapeutics | 0.1 | $4.7M | 1.8M | 2.68 | |
Igm Biosciences (IGMS) | 0.1 | $4.5M | 81k | 56.15 | |
Inflarx Nv (IFRX) | 0.1 | $4.1M | 1.1M | 3.82 | |
Aptose Biosciences | 0.1 | $3.9M | 659k | 5.94 | |
Argenx Se (ARGX) | 0.1 | $3.8M | 29k | 131.72 | |
Synlogic | 0.1 | $3.5M | 2.0M | 1.72 | |
Trillium Therapeutics, Inc. Cmn | 0.1 | $3.2M | 801k | 4.04 | |
Kalvista Pharmaceuticals (KALV) | 0.1 | $3.2M | 421k | 7.65 | |
Intellia Therapeutics (NTLA) | 0.1 | $3.2M | 262k | 12.23 | |
Syndax Pharmaceuticals (SNDX) | 0.1 | $3.2M | 290k | 10.97 | |
Aerpio Pharmaceuticals | 0.0 | $2.9M | 5.2M | 0.55 | |
Immunovant (IMVT) | 0.0 | $2.8M | 180k | 15.57 | |
Nabriva Therapeutics | 0.0 | $2.7M | 4.6M | 0.58 | |
Neubase Therapeutics Ord | 0.0 | $2.6M | 371k | 7.12 | |
Iveric Bio | 0.0 | $2.6M | 750k | 3.44 | |
Aptinyx | 0.0 | $2.5M | 1.2M | 2.16 | |
Bioxcel Therapeutics (BTAI) | 0.0 | $2.4M | 107k | 22.35 | |
Agile Therapeutics | 0.0 | $2.2M | 1.2M | 1.86 | |
Arrowhead Pharmaceuticals (ARWR) | 0.0 | $2.0M | 68k | 28.77 | |
Cassava Sciences (SAVA) | 0.0 | $1.5M | 250k | 6.12 | |
Apellis Pharmaceuticals (APLS) | 0.0 | $1.4M | 51k | 26.78 | |
Rts/bristol-myers Squibb Compa | 0.0 | $1.3M | 350k | 3.80 | |
Novus Therapeutics | 0.0 | $1.2M | 3.2M | 0.39 | |
Sutro Biopharma (STRO) | 0.0 | $1.1M | 105k | 10.20 | |
Kitov Pharmaceuticals Hldgs | 0.0 | $1.1M | 3.5M | 0.31 | |
Flexion Therapeutics | 0.0 | $1.0M | 133k | 7.87 | |
Curis | 0.0 | $956k | 1.4M | 0.70 | |
Zafgen | 0.0 | $852k | 1.1M | 0.77 | |
Intersect Ent | 0.0 | $812k | 69k | 11.84 | |
Mustang Bio | 0.0 | $675k | 252k | 2.68 | |
Protagonist Therapeutics (PTGX) | 0.0 | $472k | 67k | 7.05 | |
Catabasis Pharmaceuticals Ord | 0.0 | $184k | 44k | 4.14 | |
Otonomy | 0.0 | $142k | 72k | 1.97 | |
Biolinerx (BLRX) | 0.0 | $92k | 69k | 1.33 |